On Semiconductor Earnings Show Q4 Revenue Decline

On Semiconductor Earnings reported Q4 revenue weakness and issued cautious Q1 2026 guidance, a mix that may pressure near-term share positioning and flows.

February 09, 2026·2 min read
View all news articles
Flat vector of a semiconductor chip dimming to reflect On Semiconductor Earnings Q4 revenue decline and cautious guidance.

KEY TAKEAWAYS

  • Q4 revenue fell 11% to $1.53 billion while non-GAAP EPS topped consensus.
  • Q1 revenue guidance was $1.435 billion to $1.535 billion with EPS of $0.28 to $0.38.
  • FY 2025 free cash flow totaled $1.4 billion and was fully returned via share repurchases.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

On Semiconductor Earnings (ON) reported year-over-year revenue weakness in a Feb. 9, 2026, press release, while non-GAAP earnings per share (EPS) exceeded consensus. The company issued cautious Q1 2026 guidance with a narrow revenue range and restrained profit targets.

Quarter Results and Q1 2026 Guidance

On Semiconductor’s fourth-quarter revenue totaled $1.53 billion, down 11% from $1.72 billion a year earlier. GAAP diluted EPS was $0.45, and non-GAAP diluted EPS was $0.64, surpassing the Zacks consensus of $0.62. The company reported a GAAP gross margin of 36.0% and a non-GAAP gross margin of 38.2%, with GAAP and non-GAAP operating margins at 13.1% and 19.8%, respectively. The results were disclosed in a press release without an accompanying SEC filing.

For the first quarter, management projected non-GAAP revenue between $1.435 billion and $1.535 billion, a non-GAAP gross margin of 37.4% to 39.4%, and non-GAAP operating expenses of $407 million to $422 million. Other income and expense net was forecast at a negative $7 million. Non-GAAP diluted EPS was expected to range from $0.28 to $0.38 on roughly 398 million diluted shares. The narrow revenue band and EPS range indicate a cautious near-term outlook following the revenue decline.

Cash Flow and Capital Returns

For full-year 2025, revenue reached approximately $7.1 billion. Cash from operations totaled $1.8 billion, and free cash flow was $1.4 billion, representing a 24% margin. The company returned the entire free cash flow to shareholders through $1.4 billion in share repurchases.

The quarter presented a mixed picture: declining sales alongside margins and per-share profitability that exceeded expectations, supported by strong cash generation returned to shareholders. This combination of shrinking revenue, resilient margins, and significant buybacks will shape investor and analyst assessments of the company’s near-term prospects as markets digest the results and guidance.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Trump Iran Ceasefire Markets Rally, Oil Falls

Trump Iran Ceasefire Markets Rally, Oil Falls

Trump Iran ceasefire markets prompted a rapid risk reprice as stocks rallied and oil fell after the April 7 pause, centering traders on April 10 talks.

Levi Strauss Earnings Beat, Guidance Raised

Levi Strauss Earnings Beat, Guidance Raised

Levi Strauss earnings beat and the company raised full-year guidance, boosting investor confidence and lifting shares in after-hours trading.

Anthropic Mythos Preview Targets Cybersecurity Risks

Anthropic Mythos Preview Targets Cybersecurity Risks

Anthropic Mythos Preview flagged severe software flaws and pledged credits to partners, which could accelerate enterprise adoption of defensive scanning.

Arm Holdings Downgrade by Morgan Stanley

Arm Holdings Downgrade by Morgan Stanley

Arm Holdings downgrade by Morgan Stanley shifted trader attention to slower agentic-AI royalty timing and prompted an intraday share drop.

UnitedHealth Stock Soars on Medicare Advantage Rate

UnitedHealth Stock Soars on Medicare Advantage Rate

UnitedHealth stock jumped after CMS finalized a higher Medicare Advantage rate, easing a policy overhang and boosting analyst targets and sector flows.

Apple Foldable iPhone Delay Threatens 2026 Launch

Apple Foldable iPhone Delay Threatens 2026 Launch

Apple foldable iPhone delay threatens mass production and forces suppliers to shift schedules, pressuring shares and raising short-term volatility.